GE HealthCare Technologies (GEHC) Change in Accured Expenses (2023 - 2026)
GE HealthCare Technologies (GEHC) posted Change in Accured Expenses of -$250.0 million for Q1 2026, down 303.25% on a QoQ basis from $123.0 million in Q4 2025, and down 25.0% year-over-year from -$333.3 million in Q1 2025.
GE HealthCare Technologies (GEHC) Change in Accured Expenses (2023 - 2026) Analysis & Trends
GE HealthCare Technologies' Change in Accured Expenses history runs 4 years deep, the most recent figure standing at -$250.0 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 25.0% year-over-year to -$250.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.0 million (up 134.65% YoY) and the FY2025 annual result came in at $94.0 million, up 141.03% from the prior year.
- Change in Accured Expenses was -$250.0 million for Q1 2026 at GE HealthCare Technologies, down from $123.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $178.0 million in Q3 2025 and bottomed at -$250.0 million in Q1 2026.
- A 4-year average of $13.6 million and a median of $116.0 million in 2023 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 96.98% in 2025, while the deepest fall reached 488.24% in 2025.
- GE HealthCare Technologies' Change in Accured Expenses stood at $116.0 million in 2023, then rose by 17.24% to $136.0 million in 2024, then decreased by 9.56% to $123.0 million in 2025, then slumped by 303.25% to -$250.0 million in 2026.
- Business Quant data shows GEHC's Change in Accured Expenses at -$250.0 million in Q1 2026, $123.0 million in Q4 2025, and $178.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 145.10 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | 74.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -250.00 Mn |
| Mar 31, 2026 | -250.00 Mn |
| Dec 31, 2025 | 123.00 Mn |
| Dec 31, 2025 | 123.00 Mn |
| Sep 30, 2025 | 178.00 Mn |
| Sep 30, 2025 | 178.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | -200.00 Mn |
| Mar 31, 2025 | -200.00 Mn |
| Dec 31, 2024 | 136.00 Mn |
| Dec 31, 2024 | 136.00 Mn |
| Sep 30, 2024 | 169.00 Mn |
| Sep 30, 2024 | 169.00 Mn |
| Jun 30, 2024 | -232.00 Mn |
| Jun 30, 2024 | -232.00 Mn |
| Mar 31, 2024 | -34.00 Mn |
| Mar 31, 2024 | -34.00 Mn |
| Dec 31, 2023 | 116.00 Mn |
| Dec 31, 2023 | 116.00 Mn |